A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/4178 (2006.01) A61K 31/4184 (2006.01) A61K 31/55 (2006.01) A61K 45/06 (2006.01) A61P 9/00 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2579716
A novel combination therapy is described for cardiovascular diseases, in particular essential hypertension, pulmonary hypertension and/or congestive heart failure, involving administering a synergistic combination of at least one inhibitor of neutral endopeptidase, at least one inhibitor of the endogenous endothelin producing system and at least one AT1 receptor antagonist.
L'invention concerne une nouveau traitement combiné pour les maladies cardiovasculaires, en particulier l'hypertension artérielle essentielle, l'hypertension pulmonaire et/ou l'insuffisance cardiaque congestive, impliquant l'administration d'une combinaison synergique d'au moins un inhibiteur de l'endopeptidase neutre, d'au moins un inhibiteur du système de production de l'endothéline endogène et d'au moins un antagoniste du récepteur AT1.
Fischer Yvan
Hoeltje Dagmar
Straub Matthias
Thormaehlen Dirk
Witte Klaus
Mccarthy Tetrault Llp
Solvay Pharmaceuticals Gmbh
LandOfFree
Pharmaceutical compositions comprising nep-inhibitors,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising nep-inhibitors,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising nep-inhibitors,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1595249